{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:20:38Z","timestamp":1791829238453,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002797","name":"Government of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["NMGIRT2216"],"award-info":[{"award-number":["NMGIRT2216"]}],"id":[{"id":"10.13039\/501100002797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["824RC500"],"award-info":[{"award-number":["824RC500"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["FAMP202107K"],"award-info":[{"award-number":["FAMP202107K"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M712153"],"award-info":[{"award-number":["2022M712153"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22367007"],"award-info":[{"award-number":["22367007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304384"],"award-info":[{"award-number":["82304384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2020MS08103"],"award-info":[{"award-number":["2020MS08103"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.apsb.2025.02.030","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:29:30Z","timestamp":1740745770000},"page":"2134-2155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Zhipei","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanchan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-0925","authenticated-orcid":false,"given":"Jianta","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghuai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.02.030_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/d41586-018-05717-6","article-title":"Alzheimer's disease","volume":"559","author":"Hodson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.02.030_bib3","series-title":"World Alzheimer Report 2023: reducing dementia risk: never too early, never too late","author":"Long","year":"2023"},{"key":"10.1016\/j.apsb.2025.02.030_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.02.030_bib5","first-page":"43","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2025.02.030_bib6","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.apsb.2025.02.030_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14740338.2020.1721456","article-title":"An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"19","author":"Haake","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.apsb.2025.02.030_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.adk0830","article-title":"Side effects loom over Alzheimer's drugs","volume":"381","author":"Couzin-Frankel","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.02.030_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","article-title":"The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Wu","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.apsb.2025.02.030_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","article-title":"Multi-target drugs for Alzheimer's disease","volume":"45","author":"Turgutalp","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2025.02.030_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114464","article-title":"Alzheimer's disease: updated multi-target therapeutics are in clinical and in progress","volume":"238","author":"Sang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib12","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining cholinergic therapy for Alzheimer's disease","volume":"145","author":"Giacobini","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2025.02.030_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2025.02.030_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.apsb.2025.02.030_bib15","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.lfs.2007.03.011","article-title":"Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice","volume":"80","author":"Girard","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2025.02.030_bib16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1471-4159.2000.751320.x","article-title":"Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse","volume":"75","author":"Li","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2025.02.030_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/17425250902915555","article-title":"The butyrylcholinesterase knockout mouse: a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease","volume":"5","author":"Duysen","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2025.02.030_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","article-title":"Physiological roles for butyrylcholinesterase: a BChE\u2013ghrelin axis","volume":"259","author":"Brimijoin","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.apsb.2025.02.030_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2006.11.005","article-title":"A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India","volume":"378","author":"Manoharan","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.apsb.2025.02.030_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar beta-amyloid in an Alzheimer mouse model","volume":"98","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2025.02.030_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2015.08.026","article-title":"Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.apsb.2025.02.030_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib23","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1021\/acs.jafc.3c08951","article-title":"Design, synthesis, and 3D-QASR of 2-Ar-1,2,3-triazole derivatives containing hydrazide as potential fungicides","volume":"72","author":"Yin","year":"2024","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2016.02.020","article-title":"Design, synthesis, and structure\u2013activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2","volume":"112","author":"Zou","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib25","doi-asserted-by":"crossref","first-page":"111958","DOI":"10.1016\/j.ejmech.2019.111958","article-title":"Apigenin\u2013rivastigmine hybrids as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"187","author":"Sang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib26","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41380-024-02473-0","article-title":"The glutamatergic system in Alzheimer's disease: a systematic review with meta-analysis","volume":"29","author":"Soares","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.apsb.2025.02.030_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2016.12.064","article-title":"Formononetin attenuates A\u03b225\u201335-induced cytotoxicity in HT22 cells via PI3K\/Akt signaling and non-amyloidogenic cleavage of APP","volume":"639","author":"Chen","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.apsb.2025.02.030_bib28","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3109\/03639045.2012.693503","article-title":"A study of the chemical and biological stability of vasoactive intestinal peptide","volume":"39","author":"Cui","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.apsb.2025.02.030_bib29","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.apsb.2022.08.017","article-title":"Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: boosting the safety and metabolic stability","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib30","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1016\/j.apsb.2023.07.008","article-title":"Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility","volume":"13","author":"Zhao","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112180","article-title":"The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"192","author":"Sang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib33","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1016\/j.apsb.2022.05.017","article-title":"Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease","volume":"12","author":"Bai","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304545","article-title":"Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer's disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2025.02.030_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112265","article-title":"Design, synthesis and biological evaluation of novel O-carbamoyl ceramide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease","volume":"194","author":"Sang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib36","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1016\/j.apsb.2022.08.025","article-title":"Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses","volume":"12","author":"Chen","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib37","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.apsb.2023.01.013","article-title":"8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases","volume":"13","author":"Knez","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib38","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.apsb.2023.11.024","article-title":"A novel dual serotonin transporter and M-channel inhibitor D01 for antidepression and cognitive improvement","volume":"14","author":"Wei","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.apsb.2019.10.001","article-title":"Current trends in drug metabolism and pharmacokinetics","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116289","article-title":"Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: enhancing aqueous solubility by disrupting molecular plane","volume":"268","author":"Xing","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apsb.2014.03.002","article-title":"Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin","volume":"4","author":"Wu","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib42","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","article-title":"Design, synthesis, and evaluation of orally bioavailable quinoline-indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer's disease","volume":"61","author":"Wang","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.02.030_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.apsb.2019.07.006","article-title":"Discovery of nitazoxanide-based derivatives as autophagy activators for the treatment of Alzheimer's disease","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.02.030_bib44","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/527S6a","article-title":"Proteomics: high-protein research","volume":"527","author":"Savage","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.02.030_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106299","article-title":"Investigation of the bactericidal mechanism of penicilazaphilone C on Escherichia coli based on 4D label-free quantitative proteomic analysis","volume":"179","author":"Zhao","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.apsb.2025.02.030_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ceca.2014.05.002","article-title":"The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology, and Akt activity in the PSAPP Alzheimer's disease mouse model","volume":"56","author":"Afanador","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.apsb.2025.02.030_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jalz.2016.12.012","article-title":"Alzheimer's Disease Genetics Consortium. Transethnic genome-wide scan identifies novel Alzheimer's disease loci","volume":"13","author":"Jun","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.apsb.2025.02.030_bib48","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","article-title":"Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood","volume":"26","author":"Ou","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.apsb.2025.02.030_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115288","article-title":"Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline","volume":"326","author":"Lane","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.apsb.2025.02.030_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102339","article-title":"Reelin links apolipoprotein E4, tau, and amyloid-\u03b2 in Alzheimer's disease","volume":"98","author":"Yi","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.02.030_bib51","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.18632\/aging.101589","article-title":"Re-exploring the core genes and modules in the human frontal cortex during chronological aging: insights from network-based analysis of transcriptomic studies","volume":"10","author":"Xu","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.apsb.2025.02.030_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689629","article-title":"Electroacupuncture improves M2 microglia polarization and glia anti-inflammation of hippocampus in Alzheimer's disease","volume":"15","author":"Xie","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.apsb.2025.02.030_bib53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.3332","article-title":"Alzheimer's and prion diseases: PDK1 at the crossroads","volume":"19","author":"Checler","year":"2013","journal-title":"Nat Med"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:19:24Z","timestamp":1762604364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2211383525001078"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.02.030","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}